While this packaging protects the DNA from some forms of damage, it also limits the sperm cells ability to repair oxidative damage, such as DNA fragmentation caused by ROS
6 While many of these agents, such as RAAS blockers, effectively attenuate adverse general cardiac remodeling and improve survival by targeting specific signaling pathways, significant gaps remain in addressing key disease-driving mechanisms, such as chronic inflammation, fibrosis, and metabolic dysregulation
Their non-peptide formulation also addresses several limitations associated with injectable biologics, making them an attractive alternative for the long-term management of type 2 diabetes and obesity
Furthermore, emerging evidence links early embryonic neurodevelopmental impairments to long-term PD risk, revealing a new dimension for protective interventions
In combination with metformin and rosiglitazone, sitagliptin provided significant improvements in A1C, FPG, and 2-hour PPG compared to placebo with metformin and rosiglitazone (Table 12) at Week 18
